44,092 Shares in Kenvue Inc. (NYSE:KVUE) Bought by Man Group plc

Man Group plc bought a new position in Kenvue Inc. (NYSE:KVUE - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 44,092 shares of the company's stock, valued at approximately $941,000.

Other institutional investors have also recently made changes to their positions in the company. Handelsbanken Fonder AB lifted its holdings in shares of Kenvue by 2.9% in the 4th quarter. Handelsbanken Fonder AB now owns 742,184 shares of the company's stock worth $15,846,000 after acquiring an additional 21,222 shares during the last quarter. Alberta Investment Management Corp lifted its holdings in Kenvue by 23.2% during the 4th quarter. Alberta Investment Management Corp now owns 582,895 shares of the company's stock valued at $12,445,000 after buying an additional 109,700 shares in the last quarter. Longbow Finance SA lifted its holdings in Kenvue by 5.0% during the 4th quarter. Longbow Finance SA now owns 280,568 shares of the company's stock valued at $5,990,000 after buying an additional 13,287 shares in the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in Kenvue by 143.1% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 47,938 shares of the company's stock valued at $1,023,000 after buying an additional 28,216 shares in the last quarter. Finally, CORDA Investment Management LLC. lifted its holdings in Kenvue by 1.4% during the 4th quarter. CORDA Investment Management LLC. now owns 1,253,096 shares of the company's stock valued at $26,754,000 after buying an additional 17,466 shares in the last quarter. Institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

A number of research firms have commented on KVUE. Barclays raised their target price on shares of Kenvue from $22.00 to $23.00 and gave the company an "equal weight" rating in a research report on Monday, May 12th. Redburn Atlantic began coverage on shares of Kenvue in a research report on Thursday, April 10th. They issued a "neutral" rating and a $23.50 price objective on the stock. Evercore ISI started coverage on shares of Kenvue in a research report on Monday, March 24th. They issued an "in-line" rating and a $25.00 price objective on the stock. UBS Group lifted their target price on shares of Kenvue from $24.00 to $25.00 and gave the stock a "neutral" rating in a research note on Friday, May 9th. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $24.00 target price on shares of Kenvue in a research note on Monday, February 3rd. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. According to data from MarketBeat.com, Kenvue currently has an average rating of "Hold" and an average price target of $25.33.

Kenvue Stock Performance

NYSE KVUE traded down $0.03 on Thursday, hitting $23.53. 4,810,838 shares of the company's stock traded hands, compared to its average volume of 16,287,194. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. Kenvue Inc. has a 1-year low of $17.67 and a 1-year high of $25.17. The firm's 50-day moving average price is $23.25 and its two-hundred day moving average price is $22.64. The firm has a market capitalization of $45.14 billion, a PE ratio of 44.40, a P/E/G ratio of 2.62 and a beta of 1.02.

Kenvue (NYSE:KVUE - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.01. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. The firm had revenue of $3.74 billion during the quarter, compared to analysts' expectations of $3.69 billion. During the same period in the previous year, the business posted $0.28 EPS. The business's revenue was down 3.9% compared to the same quarter last year. As a group, analysts expect that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 28th. Investors of record on Wednesday, May 14th were paid a $0.205 dividend. This represents a $0.82 annualized dividend and a dividend yield of 3.49%. The ex-dividend date of this dividend was Wednesday, May 14th. Kenvue's dividend payout ratio is currently 149.09%.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.